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1. Introduction 
Polynlorphonuclear (PMN) neutrophil granulocytes 
react with increased adherence, chemotaxis, degranu- 
lation, oxidative metabolism and bacterial killing 
after contact with substances generated in an inflam- 
matory or infected site, e.g., the CSa-fragment and 
bacterial products, such as fMLP. Although critical 
for host defence, these mediators are also responsible 
for part of the tissue damage characterizing inflamma- 
tion because of release of PMN Iysosomal enzymes 
and formation of toxic oxygen radicals [l-4]. 
A novel group of mediators of inflammation are 
called leukotrienes [5]. These are formed within 
PMNs after stimulation with fMLP or the calcium 
ionophore A 23 I87 by a lipoxygenase~dependent 
oxygenation of arachidonic acid. The generated 
epoxide leukotriene A4 (LTA4) is unstable and con- 
verted to leukotriene B4 (LTB4, 5,12-dihydroxyeico- 
satetraenoic acid) by enzymatic hydrolysis. Two other 
5 ,12-dihydroxy isomers {compounds I and ZI) can 
also be formed by a non-enzymatic hydrolysis of 
LTA4. Further, leukotriene C4 (LTC& is formed 
from LTA4 by adding glutathione, and can be metab- 
olized to LTD4 by elimination of its y-glutamyl resi- 
due. LTC4 and LTD4 have been identified in SRS-A 
from various sources, beirlgpotent bronchoconstri~tors 
and increasing permeability of the microvasculature 
LTB4 stimulates neutrophil migration (in vitro and 
in vivo), aggregation and, to a lesser degree, degranula- 
tion ]7--lo]. Also, the lipoxygenase product S-hy- 
droxyeico~tetraenoic acid (5-HETE) has been report- 
ed to elicit a ehemotactic response and cause release 
of Iysosomal enzymes [ II]. This report concerns 
further investigations of the effects on the release of 
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lysosomal enzymes from PMNs by LTB4, its isomers 
compounds I and II, LTC4 and 5-HETE, documenting 
the stereospecificity of LTB4 and the only partial 
dependence of cytoch~asin B for this reaction. 
2. Methods 
2.1. Leukocyfe preparation 
Erythrocytes in heparinized (10 IU heparin -” 
without preservative/ml blood) human venous 
blood, obtained in sterile plastic tubes (Nunc, 
Denmark) were sedimented in 4.5% dextran T-500 at 
room temperature for 45 min [12]. The leukocyte- 
rich supernatant was centrifuged at 500 X g for 6 min. 
The cellular pellet was washed twice in heparinized 
0.9% saline (1 IU h~parin/~ saline). The leukocytes 
were resuspended, to make an appropriate neutrophil 
concentration, in Hank’s balanced salt solution 
(HBSS) containing 0.1% gelatin. 
2.2. Leukotrienes 
LTB4, compounds I and II and LTC4 was obtained 
after incubation of PMNs with arachidonic acid (Nu- 
Chek Prep., Elysian MN} and ionophore A 23 187 (Eli 
Lilly, Indianapolis IN). The incubate was extracted 
and purified by high-pressure chromatography [ 131. 
This was performed with a modification of the 
assay in [14]. A leukocyte suspension (0.5 ml), con- 
taining 2 X lo9 PMNjl, was preincubated with 2.5 pg 
cytochalasin B, dissolved in dimetylsulphoxide 
(DMSO, Sigma, St Louis MO at a final concentration 
of OS%), for 1.5 mm at 37°C. ~ukotrienes, or 
5-HETE, dissolved in ethanol (at a final concentration 
of l%), or CMLP, dissolved in HBSS, were added and 
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PMN DEGRANULATION incubated with the leukocytes for an additional 15 min 
at 37*C. In some experiments with leukotrienes cyto- 
chalasin B was omitted and leukocytes were incubated 
with LTs only for 15 min. The reaction was stopped 
by lowering the temperature rapidly to t4”C. The 
cells were sedimented by centrifugation at 200 X g 
for 5 min and the cell-free supernatants were col- 
lected. These were assayed for the activity of /3-glu- 
curonidase by measuring the release of phenolphtalein 
after 24 h incubation with phenolphtaleinglucuronic 
acid as substrate at 37°C El.51 and of lysozyme by 
measuring the lysis of Micrococcus lysodeikticus with 
the micrococcus plate method [ 16). Human lysozyme 
(State Bacteriological Lab.) was used as a standard at 
pH 7.5. To assess the unspecific leakage of cytoplasmic 
enzymes, lactate dehydrogenas (LDH), and its iso- 
enzymes I-5, were measured [ 171. 
The stimulated net release of enzymes was expressed 
as % total cellular enzyme content, determined after 
lysis of PMNs with 0.2% Triton X-100 (Sigma). 
Neither LTs, S-HETE, fMLP, cytochalasin B or 
ethanol, at these concentrations, influenced the assays 
of lysozyme or &Iucuronidase, Controls were incu- 
bated with solvent only. At the concentrations used 
neither cytochalasin B or ethanol, nor their combina- 
tions, caused any release of enzymes compared with 
controls containing only leukocytes (mean 7.1% for 
~-~ucuronidase and 5.6% for lysozyme). Experi- 
ments with cytochalasin B treated PMNs had shown 
that IMLP at lo-’ M caused a mean net release of 
15.3% of the total cellular content of P-glucuronidase 
(being -99.3 U/l O6 PMN) and 18.2% for lysozyme 
(-2.4 p&/lo6 PMN), both being completed within a 
few minutes of incubation without any net release of 
LDH. 
The standard error (expressed as % of the mean) 
for the differences between 50 double deterlninations 
is 4.7% for ~-~ucuronidase and 3 .O% for lysozyme. 
3. Results 
LTB4 caused a significant release of lysozyme and 
@-glucuronidase from cytochalasin B-treated PMNs at 
10e5 M, but not at lower concentrations (flg.1). From 
PMNs not treated with cytochalasin B LTB4 at lo-’ M 
also released small amounts of lysozyme but not of 
@lucuronidase. Similarly, compound II at 10m5 M 
caused a small release of lysozyme from cytochalasin 
B-treated neutrophils but not of ~-gIucuronidase. 
However, neither compound I, LTC4 nor S-HETE 
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Fig. 1. The release of lysozyme and p-glucuronidase from 
neutrophils after stimulation with leukotrienes, S-HETE or 
fMLP, with or without pretreatment with cytochalasin B. 
The results are expressed as means and SE values for the net 
percentage of enzyme release from PMNs from duplicate 
determinations from 3 different subjects: * p < 0.05; 
** p < 0.01 (Wilcoxon’s signed rank test). 
stimulated a net secretion of any of the enzymes. 
The release of both enzymes from cytochalasin B-treat- 
ed PMNs by LTB,, at 10e5 M was -l/2 of that noted 
after stimulation with fMLP at the same concentra- 
tion. However, in contrast to LTB+ fMLP did not 
induce any net secretion of enzymes from PMNs not 
pretreated with cytochalasin B. The LTs or 5-HETE 
did not induce any net release of LDH. 
4. Discussion 
Previous observations have Linked arachidonic acid 
and its oxygenated metabolites t9 degranulation of 
neutroph~s. Thus, arachidoni~ acid caused a release 
147 
Volume 130, number 1 FEBS LETTERS July 1981 
of lysozyme [ 181 and eicosatetraynoic acid (ETYA) 
caused a dose-dependent decrease of PMN degranula- 
tion induced by the ionophore A 23 187 or fMLP 
[ 18 ,I 91. This indicates that oxygenation of arachidonic 
acid is essential for the enzyme release of human 
PMNs to these stimuli since ETYA inhibits both the 
lipoxygenase and cyclooxygenase pathways. Further, 
only high concentrations of indomethacin (shown to 
inhibit mainly cycle-oxygenase and to a lesser extent 
lipoxygenase) also hampered part of the secretary 
effect of fMLP, whereas lower concentrations (inhibit- 
ing only the cycle-oxygenase) did not affect enzyme 
release [ 191. These findings are compatible with a role 
of lipoxygenase products for neutrophil degranulation. 
When lipoxygenase metabolites of arachidonic acid 
in PMNs (5-HETE, LTC4, LTB4 and compounds I and 
II) were studied, LTB4 was found to induce a release 
of lysosomal enzymes in cells treated with cytochalasin 
B, but also in untreated cells, a response which differs 
from fMLP, the latter being completely dependent on 
cytochala& B. The reason for this discrepancy is 
unknown. The response of cytochalasin treated PMNs 
to LTB4 was l/2 the magnitude of that for fMLP at 
the same concentration. Interestingly, the secretary 
effect of LTB4 occurs at a IO-fold higher molar con- 
centration than the concentrations for optimal stimu- 
lation of neutrophil chemotaxis and adherence [20]. 
This agrees with other observations concerning fMLP 
and LTB4 [8,14,21]. Here, only one of the non- 
enzymatic isomers of LTB4 (compound II) exhibited 
a weak activity and finally, 5-HETE and LTC, did 
not show any significant effects on the release of 
enzymes. The stereospecificity in the response to 
LTB4 provides support for a physiological role for 
LTB4 as a secretagogue, possibly released by activated 
neutrophils. However, it has been hypothesized that 
LTB4 is formed mainly in order to attract more 
neutrophils to an inflammatory area [7,20] since 
LTB4 affects PMN migration and adherence at lower 
concentrations and with responses comparable with 
fMLP and C5a. Compared with fMLP, LTB4 caused 
only a small extrusion of lysosomal enzymes as shown 
here, and did not affect production of oxygen radicals 
[ 201. The clinical significances of these findings 
remains to be determined. 
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